Skip to main content
The Mathew Laboratory is focused on the investigation of epithelial-stromal interactions that drive the metastatic progression of human malignancies and the development of novel therapeutics that target these mechanisms.
Display title
Mathew Laboratory
Eyebrow
Hematology/Oncology Research
Protease-activated receptors (PARs) are a unique class of G protein-coupled receptors that play critical roles in thrombosis, inflammation, and cancer.
CRA radiologist at Tufts Medical Center lecturing to a group about a research topic.
As part of a major academic medical center, the Radiology Department considers research to be an important part of its mission.
Display title
Radiology Research
The Hu lab studies angiogenesis in cancers and in neurodegenerative diseases.

The Hematology/Oncology research teams at Tufts Medical Center in Boston, share a mission to explore the molecular mechanisms of neoplastic transformation and promoting the translation of basic research findings into diagnostics and therapies to help patients in the clinic. To achieve this objective, scientists carry out research that spans the spectrum from gene discovery to target validation for drug development.

Physician-researchers in the Tufts Medical Center William B. Schwartz Division of Nephrology lead the way in conducting clinical research to define chronic kidney disease and have written the guidelines for its medical management.
In the Covic laboratory, we study a novel class of cell surface proteins known as protease-activated receptors.
The Buchsbaum Laboratory focuses on studying signal transduction pathways underlying cancer cell growth and metastasis. In particular, we are interested in pathways involving the Rac protein, a member of the Ras superfamily that is a central player in multiple signaling pathways affecting malignant cell behavior.
Jump back to top